PALAU PHARMA’s personal data protection policy 

Right to information
Pursuant to the provisions of Law 15/1999, of 13 December, on Personal Data Protection, PALAU PHARMA informs you that the data and documentation that you provide by e-mail will form part of a file for which PALAU PHARMA S.A., which is duly recorded at the General Data Protection Register, is responsible. 

User’s consent
By sending personal data via e-mail, the sender grants his express consent to the automated processing of the said data. The user may revoke his consent at any time by merely notifying PALAU PHARMA S.A. thereof, but such revocation cannot be backdated. 

Truth of the data
The user guarantees that the personal data with which it provides PALAU PHARMA are true and accepts responsibility for informing the Group of any modification thereto. 

Rights of access, rectification, cancellation and opposition
You may exercise your right to access, rectify, cancel and oppose the processing of your personal data, in the terms and conditions provided for in LOPD. If more convenient, you may also exercise the said rights by contacting the following e-mail address: info@palaupharma.com. 

“Spamming” techniques
PALAU PHARMA does not use “spamming” techniques and will only process the data that the user transmits via e-mail. 

Security
PALAU PHARMA maintains the levels of security for data protection in accordance with Royal Decree 994/1999, of 11 June, on security measures for automated files containing personal data, and has established all the technical measures within its power to prevent the loss, misuse, alteration, unauthorised access and theft of the data with which you provide PALAU PHARMA S.A., without prejudice to informing you that Internet security measures are not invulnerable. 

With regard to any matter regarding personal data protection, you can contact us at our e-mail: Palau Pharma 

Modification of this security policy
PALAU PHARMA reserves the right to modify this data protection policy to adapt it to future legislation or case law, and sector practice, and will inform users in advance of any such modification.
© Palau Pharma 2006